{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T14:03:27Z","timestamp":1793628207548,"version":"4.5.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,14]],"date-time":"2019-06-14T00:00:00Z","timestamp":1560470400000},"content-version":"vor","delay-in-days":348,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.5604\/01.3001.0012.0916","type":"journal-article","created":{"date-parts":[[2018,6,12]],"date-time":"2018-06-12T04:08:02Z","timestamp":1528776482000},"page":"547-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":209,"title":["New Insights About Albumin and Liver Disease"],"prefix":"10.1016","volume":"17","author":[{"given":"Joana R.","family":"Carvalho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana Verdelho","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.5604\/01.3001.0012.0916_bib0005","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.5604\/01.3001.0012.0916_bib0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","article-title":"The burden of liver disease in Europe: a review of available epidemiological data","volume":"58","author":"Blachier","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0015","first-page":"217","article-title":"New concepts on the clinical course and stratification of compensated and decompensated cirrhosis","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0020","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.cgh.2006.08.007","article-title":"Natural history of patients hospitalized for management of cirrhotic ascites","volume":"4","author":"Planas","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0025","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jhep.2011.10.016","article-title":"Renal failure and cirrhosis: a systematic review of mortality and prognosis","volume":"56","author":"Fede","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0030","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies","volume":"44","author":"D\u2019Amico","year":"2006","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1665-2681(19)31601-1","article-title":"Current indications for the use of albumin in the treatment of cirrhosis","volume":"10","author":"Alves de Mattos","year":"2011","journal-title":"Ann Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0040","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0889-8553(21)00615-4","article-title":"Pathophysiology of ascites formation","volume":"21","author":"Dudley","year":"1992","journal-title":"Gastroenterol Clin North Am"},{"key":"10.5604\/01.3001.0012.0916_bib0045","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.3748\/wjg.v21.i11.3197","article-title":"Hyponatremia in cirrhosis: pathophysiology and management","volume":"21","author":"John","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.0916_bib0050","first-page":"1","article-title":"Surgery and portal hypertension","volume":"1","author":"Child","year":"1964","journal-title":"Major Probl Clin Surg"},{"key":"10.5604\/01.3001.0012.0916_bib0055","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.27322","article-title":"Posttranscriptional changes of serum albumin: clinical and prognostic significance in hospitalized patients with cirrhosis","volume":"60","author":"Domenicali","year":"2014","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0060","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00726-006-0430-y","article-title":"Sulfenic acid in human serum albumin","volume":"32","author":"Carballal","year":"2007","journal-title":"Amino Acids"},{"key":"10.5604\/01.3001.0012.0916_bib0065","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/hep.26338","article-title":"Albumin: pathophysiologic basis of its role in the treatment of cirrhosis and its complications","volume":"58","author":"Garcia-Martinez","year":"2013","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0070","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1744-9987.12024","article-title":"Human nonmercaptalbumin-2: a novel prognostic marker in chronic liver failure","volume":"18","author":"Stauber","year":"2014","journal-title":"Ther Apher Dial"},{"key":"10.5604\/01.3001.0012.0916_bib0075","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jceh.2014.08.007","article-title":"Role of human albumin in the management of complications of liver cirrhosis","volume":"4","author":"Bernardi","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0080","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcrc.2016.04.019","article-title":"Fluid management in sepsis: The potential beneficial effects of albumin","volume":"35","author":"Vincent","year":"2016","journal-title":"J Crit Care"},{"key":"10.5604\/01.3001.0012.0916_bib0085","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/09537109609023571","article-title":"Plasma albumin and platelet function: relevance to atherogenesis and thrombosis","volume":"7","author":"Mikhailidis","year":"1996","journal-title":"Platelets"},{"key":"10.5604\/01.3001.0012.0916_bib0090","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1172\/JCI0214995","article-title":"Evidence for in vivo transport of bioactive nitric oxide in human plasma","volume":"109","author":"Rassaf","year":"2002","journal-title":"J Clin Invest"},{"key":"10.5604\/01.3001.0012.0916_bib0095","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1478-3231.2005.01115.x","article-title":"Disturbances of acid-base balance in cirrhosis: a neglected issue warranting further insights","volume":"25","author":"Bernardi","year":"2005","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.0916_bib0100","doi-asserted-by":"crossref","first-page":"345","DOI":"10.4254\/wjh.v8.i7.345","article-title":"Human albumin solution for patients with cirrhosis and acute on chronic liver failure: Beyond simple volume expansion","volume":"8","author":"Valerio","year":"2016","journal-title":"World J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jhep.2013.07.020","article-title":"Effects of intravenous albumin in patients with cirrhosis and episodic hepatic encephalopathy: a randomized double-blind study","volume":"59","author":"Simon-Talero","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0110","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.3748\/wjg.v12.i9.1403","article-title":"Long-term albumin infusion improves survival in patients with cirrhosis and ascites: an unblinded randomized trial","volume":"12","author":"Romanelli","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.5604\/01.3001.0012.0916_bib0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/IJGM.S102819","article-title":"Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements","volume":"9","author":"Levitt","year":"2016","journal-title":"Int J Gen Med"},{"key":"10.5604\/01.3001.0012.0916_bib0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2004.04.005","article-title":"Albumin turnover: experimental approach and its application in health and renal diseases","volume":"347","author":"Prinsen","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.5604\/01.3001.0012.0916_bib0125","first-page":"57","article-title":"Structure and ligand binding properties of human serum albumin","volume":"37","author":"Kragh-Hansen","year":"1990","journal-title":"Dan Med Bull"},{"key":"10.5604\/01.3001.0012.0916_bib0130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1399-3011.1983.tb02099.x","article-title":"CD-resolved secondary structure of bovine plasma albumin in acid-induced isomerization","volume":"22","author":"Era","year":"1983","journal-title":"Int J Pept Protein Res"},{"key":"10.5604\/01.3001.0012.0916_bib0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.5604\/01.3001.0012.0916_bib0140","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jhep.2013.08.001","article-title":"Effective albumin concentration and cirrhosis mortality: from concept to reality","volume":"59","author":"Jalan","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0145","first-page":"138","article-title":"Intra- and extravascular distribution of albumin and immunoglobulin in man","volume":"11","author":"Rossing","year":"1978","journal-title":"Lymphology"},{"key":"10.5604\/01.3001.0012.0916_bib0150","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1093\/dnares\/4.5.351","article-title":"Sequencing of cDNA encoding serum albumin and its extrahepatic synthesis in the Mongolian gerbil, Meriones unguiculatus","volume":"4","author":"Yoshida","year":"1997","journal-title":"DNA Res"},{"key":"10.5604\/01.3001.0012.0916_bib0155","doi-asserted-by":"crossref","first-page":"11436","DOI":"10.1016\/S0021-9258(18)37976-6","article-title":"Albumin and alpha-fetoprotein gene expression in various nonhepatic rat tissues","volume":"263","author":"Nahon","year":"1988","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0012.0916_bib0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1076\/ceyr.22.3.182.5512","article-title":"Extra-hepatic expression of serum albumin mRNA in mouse retina","volume":"22","author":"Dodson","year":"2001","journal-title":"Curr Eye Res"},{"key":"10.5604\/01.3001.0012.0916_bib0165","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/ki.1994.180","article-title":"Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats","volume":"45","author":"Sun","year":"1994","journal-title":"Kidney Int"},{"key":"10.5604\/01.3001.0012.0916_bib0170","first-page":"E656","article-title":"Time course of changes in albumin synthesis and mRNA in diabetic and insulin-treated diabetic rats","volume":"248","author":"Peavy","year":"1998","journal-title":"Am J Physiol"},{"key":"10.5604\/01.3001.0012.0916_bib0175","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0167-4781(85)90025-9","article-title":"The influence of glucocorticoid on albumin synthesis and its messenger RNA in rat in vivo and in hepatocyte suspension culture","volume":"824","author":"Moshage","year":"1985","journal-title":"Biochim Biophys Acta"},{"key":"10.5604\/01.3001.0012.0916_bib0180","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj1240529","article-title":"The effect of hypophysectomy and growth hormone replacement on albumin synthesis and catabolism in the rat","volume":"124","author":"Kernoff","year":"1971","journal-title":"Biochem J"},{"key":"10.5604\/01.3001.0012.0916_bib0185","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1172\/JCI117668","article-title":"Chronic metabolic acidosis decreases albumin synthesis and induces negative nitrogen balance in humans","volume":"95","author":"Ballmer","year":"1995","journal-title":"J Clin Invest"},{"key":"10.5604\/01.3001.0012.0916_bib0190","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1053\/ajkd.2001.29215","article-title":"Acute metabolic acidosis decreases muscle protein synthesis but not albumin synthesis in humans","volume":"38","author":"Kleger","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"10.5604\/01.3001.0012.0916_bib0195","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0014-5793(89)80476-4","article-title":"Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes","volume":"242","author":"Castell","year":"1989","journal-title":"FEBS Lett"},{"key":"10.5604\/01.3001.0012.0916_bib0200","first-page":"101","article-title":"Tissue sites of catabolism of albumin in rabbits","volume":"244","author":"Yedgar","year":"1983","journal-title":"Am J Physiol"},{"key":"10.5604\/01.3001.0012.0916_bib0205","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1365-2362.2009.02189.x","article-title":"Sex differences in the association between albumin and all-cause and vascular mortality","volume":"39","author":"Grimm","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.5604\/01.3001.0012.0916_bib0210","first-page":"11","article-title":"Albumin and all-cause mortality risk in insurance applicants","volume":"42","author":"Fulks","year":"2010","journal-title":"J Insur Med"},{"key":"10.5604\/01.3001.0012.0916_bib0215","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF03324812","article-title":"Serum albumin levels as an independent predictor of 4-year mortality in a community-dwelling 80-year-old population","volume":"22","author":"Takata","year":"2010","journal-title":"Aging Clin Exp Res"},{"key":"10.5604\/01.3001.0012.0916_bib0220","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.2169\/internalmedicine.55.6931","article-title":"Serum Albumin and Cerebro-cardiovascular Mortality During a 15-year Study in a Community-based Cohort in Tanushimaru, a Cohort of the Seven Countries Study","volume":"55","author":"Umeki","year":"2016","journal-title":"Intern Me"},{"key":"10.5604\/01.3001.0012.0916_bib0225","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/HJH.0000000000000809","article-title":"Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals","volume":"34","author":"Tanaka","year":"2016","journal-title":"J Hypertens"},{"key":"10.5604\/01.3001.0012.0916_bib0230","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jama.1994.03520130074036","article-title":"Serum albumin level and physical disability as predictors of mortality in older persons","volume":"272","author":"Corti","year":"1994","journal-title":"Jama"},{"key":"10.5604\/01.3001.0012.0916_bib0235","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1152\/ajprenal.00393.2003","article-title":"Determinants of plasma water sodium concentration as reflected in the Edelman equation: role of osmotic and Gibbs-Donnan equilibrium","volume":"286","author":"Nguyen","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.5604\/01.3001.0012.0916_bib0240","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","article-title":"Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties","volume":"151","author":"Oettl","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.5604\/01.3001.0012.0916_bib0245","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1016\/j.bbagen.2013.04.036","article-title":"Redox properties of serum albumin","volume":"1830","author":"Anraku","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.5604\/01.3001.0012.0916_bib0250","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/bja\/85.4.599","article-title":"The role of albumin in critical illness","volume":"85","author":"Nicholson","year":"2000","journal-title":"Br J Anaesth"},{"key":"10.5604\/01.3001.0012.0916_bib0255","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0008-6363(02)00492-3","article-title":"Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells","volume":"55","author":"Zhang","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.5604\/01.3001.0012.0916_bib0260","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1097\/01.CCM.0000217923.53680.4C","article-title":"Commercial human albumin preparations for clinical use are immunosuppressive in vitro","volume":"34","author":"Bar-Or","year":"2006","journal-title":"Crit Care Med"},{"key":"10.5604\/01.3001.0012.0916_bib0265","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1111\/j.1525-1594.2012.01492.x","article-title":"Albumin limits mesenteric endothelial dysfunction and inflammatory response in cardiopulmonary bypass","volume":"36","author":"Doguet","year":"2012","journal-title":"Artif Organs"},{"key":"10.5604\/01.3001.0012.0916_bib0270","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00000542-200401000-00012","article-title":"Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium","volume":"100","author":"Lang","year":"2004","journal-title":"Anesthesiology"},{"key":"10.5604\/01.3001.0012.0916_bib0275","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/hep.26021","article-title":"Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms","volume":"57","author":"Bortoluzzi","year":"2013","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0280","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0076-6879(10)74011-8","article-title":"Redox state of human serum albumin in terms of cysteine-34 in health and disease","volume":"474","author":"Oettl","year":"2010","journal-title":"Methods Enzymol"},{"key":"10.5604\/01.3001.0012.0916_bib0285","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1089\/ars.2012.4702","article-title":"Redox albuminomics: oxidized albumin in human diseases","volume":"17","author":"Colombo","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.5604\/01.3001.0012.0916_bib0290","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/(SICI)1096-9136(199607)13:7<646::AID-DIA139>3.0.CO;2-J","article-title":"Role of albumin glycation on the erythrocyte aggregation: an in vitro study","volume":"13","author":"Candiloros","year":"1996","journal-title":"Diabet Med"},{"key":"10.5604\/01.3001.0012.0916_bib0295","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.biochi.2010.12.003","article-title":"The glycation of albumin: structural and functional impacts","volume":"93","author":"Rondeau","year":"2011","journal-title":"Biochimie"},{"key":"10.5604\/01.3001.0012.0916_bib0300","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.freeradbiomed.2013.03.010","article-title":"Role of oxidative stress in physiological albumin glycation: a neglected interaction","volume":"60","author":"Vlassopoulos","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.5604\/01.3001.0012.0916_bib0305","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.cca.2005.08.011","article-title":"The formation and rapid clearance of a truncated albumin species in a critically ill patient","volume":"365","author":"Bar-Or","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.5604\/01.3001.0012.0916_bib0310","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1255\/ejms.1256","article-title":"A fast and validated mass spectrometry method for the evaluation of human serum albumin structural modifications in the clinical field","volume":"19","author":"Naldi","year":"2013","journal-title":"Eur J Mass Spectrom (Chichester)"},{"key":"10.5604\/01.3001.0012.0916_bib0315","doi-asserted-by":"crossref","first-page":"516704","DOI":"10.1155\/2010\/516704","article-title":"Inhaled Anesthetics Promote Albumin Dimerization through Reciprocal Exchange of Subdomains","volume":"2010","author":"Pieters","year":"2010","journal-title":"Biochem Res Int"},{"key":"10.5604\/01.3001.0012.0916_bib0320","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/BF02285090","article-title":"Albumin binding in uraemia: quantitative assessment of inhibition by endogenous ligands and carbamylation of albumin","volume":"43","author":"Dengler","year":"1992","journal-title":"Eur J Clin Pharmacol"},{"key":"10.5604\/01.3001.0012.0916_bib0325","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.febslet.2007.03.008","article-title":"Carbamylated albumin is a potent inhibitor of polymorphonuclear neutrophil respiratory burst","volume":"581","author":"Jaisson","year":"2007","journal-title":"FEBS Lett"},{"key":"10.5604\/01.3001.0012.0916_bib0330","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.xphs.2017.03.002","article-title":"Clinical Implications Associated With the Posttranslational Modification-Induced Functional Impairment of Albumin in Oxidative Stress-Related Diseases","volume":"106","author":"Watanabe","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.5604\/01.3001.0012.0916_bib0335","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/j.1399-3011.1984.tb00933.x","article-title":"Resolution of human mercapt- and nonmercaptalbumin by high-performance liquid chromatography","volume":"24","author":"Sogami","year":"1984","journal-title":"Int J Pept Protein Res"},{"key":"10.5604\/01.3001.0012.0916_bib0340","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1021\/bi701520y","article-title":"Reactivity of sulfenic acid in human serum albumin","volume":"47","author":"Turell","year":"2008","journal-title":"Biochemistry"},{"key":"10.5604\/01.3001.0012.0916_bib0345","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1111\/j.1742-4658.2006.05341.x","article-title":"Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions","volume":"273","author":"Kawakami","year":"2006","journal-title":"Febs j"},{"key":"10.5604\/01.3001.0012.0916_bib0350","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1097\/01.CCM.0000169876.14858.91","article-title":"Heterogeneity and oxidation status of commercial human albumin preparations in clinical use","volume":"33","author":"Bar-Or","year":"2005","journal-title":"Crit Care Med"},{"key":"10.5604\/01.3001.0012.0916_bib0355","first-page":"225","article-title":"Aging-associated oxidized albumin promotes cellular senescence and endothelial damage","volume":"11","author":"Luna","year":"2016","journal-title":"Clin Interv Aging"},{"key":"10.5604\/01.3001.0012.0916_bib0360","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1002\/hep.28740","article-title":"Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure","volume":"64","author":"Claria","year":"2016","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0365","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11011-012-9351-5","article-title":"Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy","volume":"28","author":"Bosoi","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.5604\/01.3001.0012.0916_bib0370","doi-asserted-by":"crossref","first-page":"e85216","DOI":"10.1371\/journal.pone.0085216","article-title":"Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stressrelated chronic diseases","volume":"9","author":"Nagumo","year":"2014","journal-title":"PLoS One"},{"key":"10.5604\/01.3001.0012.0916_bib0375","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0380","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.nut.2003.12.006","article-title":"Problems in serum albumin measurement and clinical significance of albumin microheterogeneity in cirrhotics","volume":"20","author":"Watanabe","year":"2004","journal-title":"Nutrition"},{"key":"10.5604\/01.3001.0012.0916_bib0385","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/hep.28897","article-title":"Hyperoxidized albumin modulates neutrophils to induce oxidative stress and inflammation in severe alcoholic hepatitis","volume":"65","author":"Das","year":"2017","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0390","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbadis.2008.04.002","article-title":"Oxidative damage of albumin in advanced liver disease","volume":"1782","author":"Oettl","year":"2008","journal-title":"Biochim Biophys Acta"},{"key":"10.5604\/01.3001.0012.0916_bib0395","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1111\/liv.12860","article-title":"Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis","volume":"35","author":"Giannone","year":"2015","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.0916_bib0400","doi-asserted-by":"crossref","first-page":"35987","DOI":"10.1038\/srep35987","article-title":"Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule","volume":"6","author":"Baldassarre","year":"2016","journal-title":"Sci Rep"},{"key":"10.5604\/01.3001.0012.0916_bib0405","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1432-1033.1995.tb20419.x","article-title":"Sitespecific N-terminal auto-degradation of human serum albumin","volume":"227","author":"Chan","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.5604\/01.3001.0012.0916_bib0410","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/hep.22913","article-title":"Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality","volume":"50","author":"Jalan","year":"2009","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0415","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1515\/cclm.2011.675","article-title":"The value of serum ischemia-modified albumin for assessing liver function in patients with chronic liver disease","volume":"49","author":"Chen","year":"2011","journal-title":"Clin Chem Lab Med"},{"key":"10.5604\/01.3001.0012.0916_bib0420","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5009\/gnl.2012.6.1.92","article-title":"Ischemia-modified albumin levels in children with chronic liver disease","volume":"6","author":"Cakir","year":"2012","journal-title":"Gut Liver"},{"key":"10.5604\/01.3001.0012.0916_bib0425","first-page":"Bc09","article-title":"The Role of Ischemia Modified Albumin as a Biomarker in Patients with Chronic Liver Disease","volume":"10","author":"Kumar","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"10.5604\/01.3001.0012.0916_bib0430","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3906\/sag-1611-66","article-title":"Serum ischemic modified albumin (IMA) concentration and IMA\/albumin ratio in patients with hepatitis B-related chronic liver diseases","volume":"47","author":"Yavuz","year":"2017","journal-title":"Turk J Med Sci"},{"key":"10.5604\/01.3001.0012.0916_bib0435","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jpba.2014.12.001","article-title":"Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases","volume":"112","author":"Naldi","year":"2015","journal-title":"J Pharm Biomed Anal"},{"key":"10.5604\/01.3001.0012.0916_bib0440","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/2110-5820-3-4","article-title":"Specific antioxidant properties of human serum albumin","volume":"3","author":"Taverna","year":"2013","journal-title":"Ann Intensive Care"},{"key":"10.5604\/01.3001.0012.0916_bib0445","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1016\/S0021-9258(17)43168-1","article-title":"Nonenzymatic glycosylation of human serum albumin alters its conformation and function","volume":"259","author":"Shaklai","year":"1984","journal-title":"J Biol Chem"},{"key":"10.5604\/01.3001.0012.0916_bib0450","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1002\/jps.23181","article-title":"Pharmaceutical aspects of the recombinant human serum albumin dimer: structural characteristics, biological properties, and medical applications","volume":"101","author":"Taguchi","year":"2012","journal-title":"J Pharm Sci"},{"key":"10.5604\/01.3001.0012.0916_bib0455","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1172\/JCI105990","article-title":"Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-(14)C","volume":"48","author":"Rothschild","year":"1969","journal-title":"J Clin Invest"},{"key":"10.5604\/01.3001.0012.0916_bib0460","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1002\/hep.20720","article-title":"Albumin: biochemical properties and therapeutic potential","volume":"41","author":"Quinlan","year":"2005","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0465","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0168-8278(00)80423-7","article-title":"Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem","volume":"32","author":"Arroyo","year":"2000","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0470","doi-asserted-by":"crossref","unstructured":"EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. J Hepatol 2010; 53: 397-417.","DOI":"10.1016\/j.jhep.2010.05.004"},{"key":"10.5604\/01.3001.0012.0916_bib0475","unstructured":"BA R. Practice guideline - Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012. American Association for The Study of Liver Diseases - AASLD 2012; 1-96."},{"key":"10.5604\/01.3001.0012.0916_bib0480","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jhep.2012.06.013","article-title":"Albumin for bacterial infections other than spontaneous bacterial peritonitis in cirrhosis. A randomized, controlled study","volume":"57","author":"Guevara","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0485","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.jhep.2014.11.017","article-title":"Effect of albumin in cirrhotic patients with infection other than spontaneous bacterial peritonitis. A randomized trial","volume":"62","author":"Thevenot","year":"2015","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0490","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/jgh.13666","article-title":"Randomized controlled trial comparing lactulose plus albumin versus lactulose alone for treatment of hepatic encephalopathy","volume":"32","author":"Sharma","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0495","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0168-8278(98)80288-2","article-title":"Hemodynamic changes in patients developing effective hypovolemia after total paracentesis","volume":"28","author":"Vila","year":"1998","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0500","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1053\/gast.1997.v113.pm9247479","article-title":"Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis","volume":"113","author":"Ruiz-del-Arbol","year":"1997","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.0916_bib0505","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1002\/hep.24786","article-title":"Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials","volume":"55","author":"Bernardi","year":"2012","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0510","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0168-8278(97)80081-5","article-title":"Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis","volume":"27","author":"Salo","year":"1997","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0515","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/00365520902912555","article-title":"Ascites: pathogenesis and therapeutic principles","volume":"44","author":"Moller","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.5604\/01.3001.0012.0916_bib0520","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/0016-5085(88)90691-9","article-title":"Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis","volume":"94","author":"Gines","year":"1988","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.0916_bib0525","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0016-5085(96)70068-9","article-title":"Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis","volume":"111","author":"Gines","year":"1996","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.0916_bib0530","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-2008-1040320","article-title":"The management of ascites and hyponatremia in cirrhosis","volume":"28","author":"Gines","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.5604\/01.3001.0012.0916_bib0535","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1478-3231.2010.02272.x","article-title":"Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis","volume":"30","author":"Salerno","year":"2010","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.0916_bib0540","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hep.27106","article-title":"Trial sequence meta-analysis can reject false-positive result calculated from conventional meta-analysis","volume":"60","author":"Chen","year":"2014","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0545","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jgh.13421","article-title":"Insufficient evidence of benefit regarding mortality due to albumin substitution in HCC-free cirrhotic patients undergoing large volume paracentesis","volume":"32","author":"Kutting","year":"2017","journal-title":"J Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0550","first-page":"881","article-title":"Prevention of paracentesis-induced circulatory dysfunction in cirrhosis: standard vs half albumin doses. A prospective, randomized, unblinded pilot study","volume":"43","author":"Alessandria","year":"2011","journal-title":"Dig Liver Dis"},{"key":"10.5604\/01.3001.0012.0916_bib0555","first-page":"592","article-title":"Low dose albumin for the prevention of renal impairment following large volume paracentesis in cirrhosis","volume":"31","author":"Hussain","year":"2015","journal-title":"Pak J Med Sci"},{"key":"10.5604\/01.3001.0012.0916_bib0560","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1478-3231.2008.01734.x","article-title":"Prevention of paracentesis-induced circulatory dysfunction: midodrine vs albumin. A randomized pilot study","volume":"28","author":"Appenrodt","year":"2008","journal-title":"Liver Int"},{"key":"10.5604\/01.3001.0012.0916_bib0565","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/j.1572-0241.2008.01787.x","article-title":"Midodrine versus albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotics: a randomized pilot study","volume":"103","author":"Singh","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.5604\/01.3001.0012.0916_bib0570","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/MCG.0b013e31829ae376","article-title":"Comparison of midodrine and albumin in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients: a randomized pilot study","volume":"48","author":"Hamdy","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"10.5604\/01.3001.0012.0916_bib0575","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1751-2980.12304","article-title":"Effects of midodrine in patients with ascites due to cirrhosis: Systematic review and meta-analysis","volume":"17","author":"Guo","year":"2016","journal-title":"J Dig Dis"},{"key":"10.5604\/01.3001.0012.0916_bib0580","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2796.2006.01654.x","article-title":"Noradrenaline and albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized pilot study","volume":"260","author":"Singh","year":"2006","journal-title":"J Intern Med"},{"key":"10.5604\/01.3001.0012.0916_bib0585","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1136\/gut.50.1.90","article-title":"Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study","volume":"50","author":"Moreau","year":"2002","journal-title":"Gut"},{"key":"10.5604\/01.3001.0012.0916_bib0590","first-page":"1930","article-title":"The efficacy of terlipressin in comparison with albumin in the prevention of circulatory changes after the paracentesis of tense ascites\u2014a randomized multicentric study","volume":"54","author":"Lata","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.5604\/01.3001.0012.0916_bib0595","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/hep.1840200619","article-title":"Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis","volume":"20","author":"Follo","year":"1994","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0600","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/jhep.2003.50447","article-title":"Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis","volume":"38","author":"Ruiz-del-Arbol","year":"2003","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0605","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"10.5604\/01.3001.0012.0916_bib0610","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cgh.2012.11.007","article-title":"Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials","volume":"11","author":"Salerno","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0615","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1136\/gut.2006.113050","article-title":"Restricted use of albumin for spontaneous bacterial peritonitis","volume":"56","author":"Sigal","year":"2007","journal-title":"Gut"},{"key":"10.5604\/01.3001.0012.0916_bib0620","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cgh.2011.11.012","article-title":"Role of albumin treatment in patients with spontaneous bacterial peritonitis","volume":"10","author":"Poca","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0625","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1136\/gutjnl-2011-301739","article-title":"Lowdose albumin in the treatment of spontaneous bacterial peritonitis: should we change the standard treatment","volume":"61","author":"de Araujo","year":"2012","journal-title":"Gut"},{"key":"10.5604\/01.3001.0012.0916_bib0630","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/MEG.0000000000000635","article-title":"Effect of different therapeutic modalities on systemic, renal, and hepatic hemodynamics and short-term outcomes in cirrhotic patients with spontaneous bacterial peritonitis","volume":"28","author":"Salman","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl. 1","key":"10.5604\/01.3001.0012.0916_bib0635","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0168-8278(12)60002-6","article-title":"Management of bacterial infections in cirrhosis","volume":"56","author":"Fernandez","year":"2012","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0640","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J Hepatol"},{"key":"10.5604\/01.3001.0012.0916_bib0645","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1053\/jhep.2002.35819","article-title":"Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: results of a prospective, nonrandomized study","volume":"36","author":"Ortega","year":"2002","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0012.0916_bib0650","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Martin-Llahi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.0916_bib0655","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0012.0916_bib0660","doi-asserted-by":"crossref","first-page":"292","DOI":"10.5009\/gnl.2009.3.4.292","article-title":"Renal Dysfunction Induced by Bacterial Infection other than Spontaneous Bacterial Peritonitis in Patients with Cirrhosis: Incidence and Risk Factor","volume":"3","author":"Kim","year":"2009","journal-title":"Gut Liver"},{"key":"10.5604\/01.3001.0012.0916_bib0665","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/hep.21443","article-title":"Renal failure and bacterial infections in patients with cirrhosis: epidemiology and clinical features","volume":"45","author":"Fasolato","year":"2007","journal-title":"Hepatology"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119304776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268119304776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:37:08Z","timestamp":1761647828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268119304776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1665268119304776"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0012.0916","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New Insights About Albumin and Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0012.0916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}